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Acute inflammatory profiles differ with sex
and age after spinal cord injury
Andrew N. Stewart1, John L. Lowe1,2, Ethan P. Glaser1, Caitlin A. Mott1, Ryan K. Shahidehpour3,
Katelyn E. McFarlane1, William M. Bailey1, Bei Zhang1,4 and John C. Gensel1*
Abstract
Background: Sex and age are emerging as influential variables that affect spinal cord injury (SCI) recovery. Despite
a changing demographic towards older age at the time of SCI, the effects of sex or age on inflammation remain to
be elucidated. This study determined the sex- and age-dependency of the innate immune response acutely after
SCI.
Methods: Male and female mice of ages 4- and 14-month-old received T9 contusion SCI and the proportion of
microglia, monocyte-derived macrophages (MDM), and neutrophils surrounding the lesion were determined at 3-
and 7-day post-injury (DPI) using flow cytometry. Cell counts of microglia and MDMs were obtained using
immunohistochemistry to verify flow cytometry results at 3-DPI. Microglia and MDMs were separately isolated using
fluorescence-activated cell sorting (FACS) at 3-day post-injury (DPI) to assess RNA expression of 27 genes associated
with activation, redox, and debris metabolism/clearance.
Results: Flow cytometry revealed that being female and older at the time of injury significantly increased MDMs
relative to other phagocytes, specifically increasing the ratio of MDMs to microglia at 3-DPI. Cell counts using
immunohistochemistry revealed that male mice have more total microglia within SCI lesions that can account for a
lower MDM/microglia ratio. With NanoString analyses of 27 genes, only 1 was differentially expressed between
sexes in MDMs; specifically, complement protein C1qa was increased in males. No genes were affected by age in
MDMs. Only 2 genes were differentially regulated in microglia between sexes after controlling for false discovery
rate, specifically CYBB (NOX2) as a reactive oxygen species (ROS)-associated marker as well as MRC1 (CD206), a gene
associated with reparative phenotypes. Both genes were increased in female microglia. No microglial genes were
differentially regulated between ages. Differences between microglia and MDMs were found in 26 of 27 genes
analyzed, all expressed higher in MDMs with three exceptions. Specifically, C1qa, cPLA2, and CD86 were expressed
higher in microglia.
Conclusions: These findings indicate that inflammatory responses to SCI are sex-dependent at both the level of
cellular recruitment and gene expression.
Keywords: Acute inflammation, Aging, Gender, Macrophage phenotype, Neurotrauma, P2y12 receptor, Sex as a
biological variable
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Introduction
Inflammation occurring after spinal cord injury (SCI)
plays a juxtaposing role by promoting both tissue repair
while further exacerbating tissue damage [1, 2]. Innate
immune cells including neutrophils and monocyte-
derived macrophages (MDM) that infiltrate the damaged
spinal cord, along with activated resident microglia, aid
in clearing cellular debris [3, 4]. Cytokines, growth fac-
tors, enzymes, and proteases released by inflammatory
leukocytes and microglia participate in tissue remodeling
that encourages axon sprouting and cellular migration,
which can promote both functional recovery and aber-
rant plasticity [2]. Similarly, myeloid cells aid in clearing
cellular debris but also produce high quantities of react-
ive oxygen species (ROS) that further exacerbate spinal
damage after injury [5].
Despite increased efforts to understand the relative
contribution of different innate immune cells in the
pathophysiology of SCI; it remains important to better
characterize inflammatory profiles within the injured en-
vironment and delineate differences between the func-
tional roles of MDMs and microglia acutely after SCI.
Microglia function as early phagocytic responders to
local spinal damage and begin clearing cellular debris,
while infiltrating MDMs assume the burden of debris
clearance by 3-day post-injury [3] (DPI). Delineating
functional differences between MDMs and microglia
after SCI is considerably challenged due to a changing
spatial and temporal environment following injury. To
compound this complexity, emerging evidence also sug-
gests that physiologic variables such as sex or age at the
time of neurotrauma can change inflammatory responses
[6–9]. Whether similar interactions exist following SCI
is understudied.
This study aimed to determine if sex and age at the
time of SCI affect the inflammatory response of MDMs
and microglia acutely following injury. Fluorescence-
activated cell sorting (FACS) and immunohistochemistry
were used to characterize the inflammatory profiles of
infiltrating MDMs and neutrophils, as well as resident
microglia. MDMs and microglia were collected at 3-DPI
and analyzed for the expression of 27 genes associated
with macrophage activation, reactive oxygen species
(ROS) production, and debris clearance. Flow cytometry
revealed an increased proportion of infiltrating MDMs
relative to microglia and neutrophils at 3-DPI in females,
which is consistent with a larger microglial response in
males detected using immunohistochemistry. Gene ex-
pression analysis indicated that most genes associated
with conventionally defined M1 and M2 phenotypes, as
well as genes associated with ROS, were increased at
higher levels in MDMs compared to microglia. However,
CD86, the complement protein C1qa, and cPLA2 were
increased in microglia. A sex-dependent increase in
C1qa was also found in male MDMs, and an increase in
the gene encoding NADPH-Oxidase (NOX2), CYBB, as
well as M2-associated gene MRC1, were increased in fe-
male microglia. Collective data derived from this study




All procedures are approved by the University of Ken-
tucky’s Institutional Animal Care and Use Committee.
In total, 74 female and male C57Bl/6 mice of ages 4- (n=
33; Jackson Laboratories), and 14-month old (MO; n=41;
derived from Jackson Laboratory but aged by the Na-
tional Institute on Aging) received laminectomy only as
a sham injury, or laminectomy with 60- or 75-kDyn SCI
under ketamine (100.0 mg/kg) and xylazine (10.0 mg/kg)
anesthesia as previously described using the Infinite Ho-
rizons Impactor (Precision Systems Instrumentation,
LLC, Fairfax Station, VA) [10]. After SCI, all mice re-
ceived buprenorphine (Buprenex SR, 1.0 mg/kg day of
surgery), as well as an antibiotic (Enrofloxacin, 5.0 mg/
kg) dissolved in saline (1.0 mL/day) for up to 5 days
post-SCI. Manual bladder expressions were performed
2x/day for the duration of the study. Mice of ages 4- and
14-MO were chosen as a representative shift in average
clinical demographics from 27 to 43 years old at the
time of SCI since the 1970s [11].
Flow cytometry
Myeloid cell isolation
Mice receiving 75 kDyn SCI were anesthetized at 3- and
7-DPI using an overdose of ketamine and xylazine and
were perfused using sterile 0.01 M phosphate-buffered
saline (PBS) containing 1.0 mM EDTA. An 8.0-mm sec-
tion of the spinal cord surrounding the SCI lesion was
dissected and placed in a digestion buffer containing a 1:
1 solution of RPMI and Accumax (Thermo Fisher Scien-
tific, Waltham, MA). The cords were mashed through a
70-μm diameter meshing into a 30% Percoll solution di-
luted in RPMI (Thermo Fisher Scientific, Waltham,
MA). Cells were centrifuged at 1500 G for 15 min at
10oC to pellet cells, and the floating myelin layer was as-
pirated. Myeloid cells and debris were then suspended in
red blood cell lysis buffer and pelleted. Cells were
washed in PBS and suspended in cell staining buffer
(Cat #: 420201; Biolegend, San Diego, CA) for antibody
labeling.
In total, n=35 mice were used for flow cytometry ex-
periments split between 3- (n=23) and 7-DPI (n=12). For
the 3-DPI experiments, female (n=3, 4-MO and n=5, 14-
MO) and male (n=3, 4-MO and n=6, 14-MO) mice sur-
vived until perfusions and were used for flow cytometry
experiments. For the 7-DPI experiments, female (n=3, 4-
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and 14-MO) and male (n=3, 4-MO; and n=2 14-MO)
mice survived until perfusions. There was a loss of 4-
(n=1) and 14-MO (n=2) females, as well as 14-MO (n=
3) males which died within the first 72-h for the 3-DPI
experiment, and n=1, 14-MO male that died at 4-DPI in
the 7-DPI experiment. The imbalance in final animal
numbers between groups is due to increased 14-MO an-
imals being initiated in the experiment to compensate
for a higher expected mortality. Consequently,
more older mice ended up in the 3-DPI experiment des-
pite this increased mortality. Sham mice were not per-
formed because the uninjured spinal cords do not
contain neutrophils or MDMs.
Antibody labeling and FACS
Endogenous Fc receptors were blocked for 15 min on
ice using neutralizing antibodies targeting CD16/32 (1:
100; Fc Block; Cat #: 553142; BD Biosciences, San Jose,
CA). Next, cells obtained from the spinal cord were
washed and resuspended in an antibody cocktail labeling
all cells of the myeloid and lymphocyte lineage (Rat anti-
CD45-APC conjugate; 1:100; Cat #: 559864; BD Biosci-
ences, San Jose, CA), as well as for the macrophage-
specific integrin marker (Rat anti-CD11b-PE conjugate;
1:200; Cat #: 553311; BD Biosciences, San Jose, CA) and
a neutrophil selection marker (Rat anti-Ly6G-PE-Cy7
conjugate; 1:50; Cat #: 560601; BD Biosciences, San Jose,
CA). Antibodies were incubated for 1 h on ice before
washing and re-suspending in cell staining buffer.
MDMs and microglia were sorted and collected in sep-
arate tubes containing cell lysis buffer (Cat #: 51800; Nor-
gen Biotek; Ontario, CAN) using FACS (iCyt sy3200; Sony
Biotechnologies; San Jose, CA). FACS was performed by
the University of Kentucky’s Flow Cytometry and Immune
Monitoring Facility. An appropriate gating strategy was
applied based on forward and side scatter plots to isolate
cells from debris, exclude doublets, and set compensations
using single-antibody controls (Fig. 1a). Experimental con-
trols consisted of no-stain, single-channel, and fluores-
cence minus one. Cells obtained from 4-MO female mice
that were designated for control purposes were used to set
compensations. MDMs (CD45+/CD11b+high/Ly6G-) and
microglia (CD45+/CD11b+low/Ly6G-) were identified and
sorted into separate tubes. Neutrophils (CD45+/CD11b+/
Ly6G+) were identified in flow plots and used for cell
profiling.
Myeloid cells isolated from injured spinal cords were
analyzed for the proportion of MDMs, microglia, and
neutrophils to all CD45+/CD11b+ cells. Similarly, MDM/
microglia ratios were used to compare total macrophage
profiles. Because tubes were emptied during FACS ana-
lysis, we also used absolute cell counts to predict total
inflammation and followed up on findings using immu-
nohistochemistry to confirm results. Flow cytometry
analysis was performed using Flowjo (v. 10.6.2; Ashland,
OR).
Gene expression using NanoString
MDM and microglial RNA was collected and purified
using a commercially available single-cell RNA purifica-
tion kit (Norgen Biotek; Cat #: 51800; Thorold, ON,
CA), and obtained RNA was quantified using Nanodrop
(Nanodrop Lite; Thermo Fisher Waltham, MA) and
tested for degradation using BioAnalyzer (Agilent Tech-
nologies; Santa Clara, CA). Because of the limited collec-
tion size of cells, between 4.0 and 15.0×103 cells/tube/
cord, RNA was eluted in 13.0 μL RNAse free-H2O. Only
samples containing sufficient purity and a quantity of at
least 25.0 ng at 2.5 ng/μL were used for RNA analysis,
RNA analysis was performed using Nanostring nCounter
(nCounter SPRINT profiler; NanoString Technologies;
Seattle, WA), available at the University of Kentucky’s
Genomics Core Laboratory. A custom code-set was cre-
ated and purchased to identify genes that our lab has
previously associated with macrophage activation and
phenotype using Taqman gene array, as well as func-
tional genes associated with ROS and myelin processing
(a full list of RNA targets can be found in Additional file
1 and is based upon previous in vitro phenotyping [12]).
In total, 59 probes were used, 6 being machine-positive
controls, 8 as machine-negative controls, 3 being house-
keeping genes for normalization, 5 being cell-type assay
controls to determine sensitivity and purity of the sort-
ing procedure, and 37 markers of macrophage pheno-
type and function. Of the 37, 10 were consistently
undetectable in the samples. Any gene with less than
75% of samples testing below the threshold was excluded
from the analysis. Of the 27 remaining detectable pheno-
typic/functional markers, 17 were designated as markers
of macrophage activation, 8 were designated as markers
of ROS, and 2 were designated markers of debris metab-
olism/clearance. NanoString nCounter was performed
according to the manufacturer’s recommendations. Data
was analyzed using Nanostring’s nSolver software, nor-
malizing values to the geometric means of the house-
keeping genes. A threshold was set to 20.0, or
approximately 2x the geometric mean of the negative
controls (geomean=10.1).
All mice used for flow cytometry experiments at 3-DPI
were utilized for NanoString analysis except n=1, 14-
MO male mouse due to degraded RNA, as well as n=1
microglia sample from a 14-MO female mouse being
below the 25-ng limit. Mice within each variable were
collapsed across the opposing variable for analyses. For
example, determining effects of sex resulted in the
grouping 4- (n=3) and 14-MO (n=4 for MDMs, n=3 for
microglia) females (n=7 and 6 in total for female MDMs
and microglia), as well as 4- (n=3) and 14-MO (n=5)
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Fig. 1 (See legend on next page.)
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males (n=8 total for male MDMs and microglia). For de-
termining effects of age, 4-MO males and females (n=6
total for each sex for both MDMs and microglia), and
14-MO males and females (n=9 for MDMs and n=8 for
microglia) were grouped together. For comparing Nano-
String profiles between MDMs (n=15) and microglia (n=
14), all samples were grouped from both sexes and ages.
Immunohistochemistry
Immunohistochemistry was performed on tissue ob-
tained at 3-DPI. The injury severity was reduced to 60
kDyn due to complications with early mortality of 14-
MO male mice at this injury severity (33.3% of our start-
ing sample) as previously discussed [13]. Briefly, 14-MO
male mice were dying overnight or becoming moribund
within a few days post-SCI which led to challenges
obtaining a sufficient sample size for flow cytometry by
7-DPI. To limit this mortality, the lesion severity was re-
duced from 75- to 60-kDyn. No early mortality occurred
for this immunohistochemistry experiment. In total, 40
mice were used for this experiment split between mice
receiving sham (n=3/group) or SCI (n=7/group). One 4-
MO female sample receiving SCI was lost due to damage
during tissue processing.
Mice were anesthetized using an overdose of ketamine
and xylazine as described above. Mice were perfused
using cardiac puncture first with 0.1 M PBS, then with
4% formaldehyde in PBS made from paraformaldehyde.
The spinal cords were extracted from mice, then post-
fixed for 2 h at room temperature and washed in 0.2 M
phosphate buffer (PB) overnight. The cords were trans-
ferred to a 30% sucrose solution for 1 week before
blocking in optimal cutting temperature compound
(OCT; Thomas Scientific; Swedesboro, NJ). The spinal
cords were blocked in a random order but ensuring a
representation of all groups in each block (n=5/block).
Blocks were cut between −18oC and -20oC at 10.0-μm
thick in the coronal plane. Each block was cut in a series
of 10 equal representative sets with 100.0 μm of z-dis-
tance between repeated sections. First, one set was
stained as previously described [8] using eriochrome cy-
anine and neurofilament (Chicken anti-NF-200; 1:1,500;
Cat #: NFH; Aves Laboratories; Davis, CA) to identify
spared tissue. The section containing the least amount
of spared tissue was considered the lesion epicenter and
was used to standardize analysis with respect to this ob-
jectively defined landmark as established previously [14].
The next set was labeled for a pan macrophage marker
(Rat anti-F4/80; 1:250; Cat #: MCA497; Bio-Rad AbD
Serotec; Oxford, UK), a microglial specific marker
(Rabbit (Rb) anti-P2y12; 1;1,000; Cat #: AS-55043A;
Anaspec Inc; Fremont, CA), and with cresyl violet for
nuclear detection. Microglial Rb anti-P2y12 was first la-
beled using a horseradish peroxidase (HRP) conjugated
goat (Gt) anti-Rb secondary antibody (Cat #: PI-1000;
Vector Labs; Burlingame, CA). P2y12 receptor was de-
tected using 3,3’-diaminobenzidine (DAB) with nickel to
label microglia black. Next, peroxidase from the first
round of labeling was quenched using 3.0% H2O2 in 0.1
M PBS for 30 min at room temperature. An HRP conju-
gated Gt anti-Rat secondary antibody (mouse absorbed;
Cat #: PI-9401; Vector Labs; Burlingame, CA) was then
bound to the Rat anti-F4/80 antibody, followed by devel-
opment using DAB without a nickel to produce a con-
trasting brown label in all macrophages. The tissue was
then counter-stained in cresyl violet for nuclear detec-
tion, then dehydrated using graded ethanol baths and
cleared using Histoclear (VWR Scientific; Radnor, PA).
Slides were coverslipped with Permount (Fisher Scien-
tific; Waltham, MA) and imaged at 20x using Axioscan
(Axioscan Z1; Carl Zeiss AG; Oberkochen, DE).
Slides were visualized and analyzed using Halo soft-
ware (Indica Labs; Albuquerque, NM). In total, 3 sec-
tions were used to analyze cell counts of MDMs and
microglia at the lesion epicenter as well as at 100-μm
rostral and caudal to the epicenter. The region of ana-
lysis was limited to within the lesion, and cells were
counted using unbiased procedures adapted from fluor-
escent labeling techniques [8]. Annotations encompass-
ing the lesion were partitioned into evenly spaced, but
randomly placed, 100-μm2 boxes. MDMs were identified
by the presence of brown labeling (F4/80) and all cells
containing a nucleus that were within the box, or touch-
ing the top or right margins, were counted. Microglia
were identified by the presence of black P2y12 labeling
which often masked nuclear cresyl violet staining; there-
fore, a standard criterion was set for counting microglia.
All P2y12 labeling that presented with a soma and at
least 5 μm of continual P2y12 staining, either in diam-
eter or length, were counted. Staining length was
(See figure on previous page.)
Fig. 1 Flow cytometry reveals different inflammatory profiles between sexes at 3-DPI. a Myeloid cells were isolated from the injured spinal cords
of male and female, 4- and 14-MO mice at 3-DPI using a consistent gating strategy. b Representative flow plots of cells that were immuno-
labeled for selection markers against all myeloid cells (CD11b and CD45) and neutrophils (Ly6G). c Female mice presented with a larger
proportion of MDMs compared to both microglia (p<0.0001), and total myeloid cells (p<0.01), with a main effect of sex for total MDM events (p<
0.05). c Male mice presented with trends towards a larger proportion of microglia to total myeloid cells (p=0.053). Sample size include: 4-MO
female (n=3), 4-MO male (n=3), 14-MO female (n=4), 14-MO male (n=6). Main effects were assessed using two-way ANOVA, followed by pairwise
comparisons using Sidak’s for post hoc analysis when appropriate. All graphs present the standard error of measurement (SEM). *p<0.05, **p<0.01
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assessed using a built-in ruler tool in Halo. Due to dif-
ferences in sizes between 4- and 14-MO mouse spinal
cords, as well as occasional rips and folds in tissue, cell
counts were normalized to the total area measured to
obtain a cell density that is comparable between groups
(examples of annotation markups and sampling proce-
dures can be found in Supplementary Figure 1). Cells
were counted by an experimenter blinded to group
identities.
Statistics
Flow cytometry and immunohistochemistry
Two-way analysis of variance (ANOVA) was used to test
the main effects of sex and age as well as for interac-
tions. Sidak’s pairwise comparisons were used as post
hoc analysis to test effects between groups when the
main effect was found significant at p ≤ 0.05. All stats
for flow cytometry and immunohistochemistry were per-
formed using Prism (v. 8.2.1; GraphPad Software, Inc.;
San Diego; CA).
NanoString gene expression
A general linear model was constructed for a two-way
multiple analysis of variance (MANOVA) to test the main
effects of sex and age as well as for interactions. Overall
effects and main effects of each gene were determined. Es-
timated marginal means (EMM) and corresponding stand-
ard error of measurements were derived from MANOVA
corrections to control for the grouped variable; i.e., cor-
recting for the age when testing for sex or correcting for
sex when testing for age. EMMs and derived standard er-
rors were used for multiple T test to determine the signifi-
cance of each gene. Significant P values are reported
separately, along with Q values obtained after controlling
for false discovery rate (FDR) using the two-stage step-up
method of Benjamini, Krieger, and Yekutieli. A significant
Q value was set to 5% to distinguish a true discovery.
MANOVA’s were performed using SPSS (v. 25; IBM;
Armonk, NY), and multiple T tests with FDR corrections
were performed using Prism (v. 8.2.1; GraphPad Software,
Inc., San Diego, CA).
Results
Flow cytometry reveals higher quantities and ratios of
MDMs in injured spinal cords of female mice
We previously identified both sex and age as important
biological variables in the pathophysiology of SCI in-
flammation and recovery [6, 14, 15]. Further, we identi-
fied that MDMs and microglia are the main producers
of ROS in the acutely injured spinal cord and that in-
creased ROS production contributes to age-dependent
functional recovery [7, 8]. Here, we sought to determine
the effect of sex and age on SCI-induced inflammation
by examining peripheral and CNS immune responses
after thoracic contusion SCI in male and female mice
aged 4 or 14 months at the time of injury.
To determine the relative responses of MDM, micro-
glia, and neutrophils to injury, we harvested myeloid
cells from the injured spinal cord at 3- (Fig. 1b) and 7-
DPI (Fig. 2a) and compared the ratios of each cell type
to the overall CD45+/CD11b+ myeloid cell populations
using flow cytometry. At 3-DPI, for MDMs (CD11b+/
CD45hi/Ly6G-), we detected a significant main effect of
sex (F(1, 12)=16.65, p<0.005; Fig. 1c). This effect was
driven by both 4- (p<0.05) and 14-MO (p<0.05) female
mice having a significant increase in the proportion of
MDMs relative to total myeloid cells compared to age-
matched males. There was no significant main effect of
age (F(1, 12)=1.14, p=0.31) in the ratio of MDM to total
myeloid cells in the spinal cord.
Next, we examined the ratio of microglia (CD11b+/
CD45lo/Ly6G-) to total myeloid cells at 3-DPI and ob-
served a trend for a main effect of sex (F(1, 12)=4.10, p=
0.06; Fig. 1c) and a sex by age interaction (F(1, 12)=3.67,
p=0.08; Fig. 1c). Both effects were driven by decreased
microglia ratios in 4-MO females that reached statistical
significance when compared to age-matched males (p=
0.05) and were decreased compared to 14-MO females
(p=0.09). There was no significant main effect of age on
the ratio of microglia to total myeloid cells (F(1, 12)=1.77,
p=0.2; Fig. 1c). The proportion of CD11b+/CD45+/
Ly6G+ neutrophils relative to total CD11b+ myeloid cells
was not significantly affected by sex (F(1, 12)=0.39, p=
0.54) nor age (F(1, 12)=0.00035, p=0.95) at 3-DPI.
Since our results indicated that both MDMs and micro-
glia are affected by age and sex, we next compared
MDMs/microglia ratios. Our flow cytometry results indi-
cate that being female and older at the time of injury in-
creases MDM infiltration into the cord at 3-DPI (Fig. 1c).
Specifically, there was a significant main effect of sex (F(1,
12)=29.80, p<0.0001; Fig. 1c) and age (F(1, 12)=5.50, p<0.05)
in MDM/microglia ratios. Both 4- (p<0.001) and 14-MO
(p<0.05) female mice had significantly higher MDMs rela-
tive to microglia ratios compared to age-matched males.
The effect of age was driven by 4-MO females having a
significantly larger proportion of MDMs compared to 14-
MO females (p<0.05). There were no significant differ-
ences between 4- and 14-MO males (p=0.93).
Examining proportions provides insight into the in-
flammatory profile after injury. To better understand the
magnitude of the myeloid cell response to SCI, we com-
pared cell counts of MDMs, microglia, and neutrophils
across groups by running the entirety of the prepared
samples through the cytometer. No differences were
found among groups for total number of myeloid cells
sampled (CD45+/CD11b+; main effect of sex F(1, 12)=
0.208, p=0.64; main effect of age F(1, 12)=3.17, p=0.09;
Fig. 1c), thereby validating our flow cytometry
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proportion and count measures. For individual cell
types, a significant main effect of sex emerged for
MDMs (F(1, 12)=6.55, p<0.05; Fig. 1d), with females hav-
ing higher numbers of MDMs than males. Post hoc ana-
lyses revealed a significant increase in 14-MO females
compared to age-matched males (p<0.05). We observed
a trend towards increased microglial counts with age
(F(1, 12)=4.06, p=0.07; Fig. 1d) largely driven by increased
microglia numbers in 14-MO females compared to 4-
MO females (p=0.08). There were no significant main ef-
fects of sex (F(1, 12)=0.16, p=0.7; Fig. 1d) in microglia
counts nor significant main effects for neutrophils in ei-
ther sex (F(1, 12)=0.47, p=0.5) or age (F(1, 12)=0.72, p=0.4).
Collectively, our flow cytometry data at 3-DPI
Fig. 2 Younger mice have a higher proportion of MDMs at 7-DPI. Myeloid cells were isolated from the injured spinal cords of male and female,
4- and 14-MO mice at 7-DPI using a consistent gating strategy (Fig. 1a). a Representative flow plots of cells that were immuno-labeled for
selection markers against all myeloid cells (CD45), phagocytic cells (CD11b), and neutrophils (Ly6G). b 4-MO mice presented with a larger
proportion of MDMs compared to total phagocytic cells (p<0.05). Sample size include 4-MO female (n=3), 4-MO male (n=3), 14-MO female (n=3),
and 14-MO male (n=2). Main effects were assessed using two-way ANOVA, followed by pairwise comparisons using Sidak’s for post hoc analysis
when appropriate. All graphs present the standard error of measurement (SEM). *p<0.05
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demonstrates that males and females differ in their in-
flammatory profiles after SCI, which is driven largely by
significant increases in monocytes relative to microglia
in females. This occurs despite a relative potentiation of
microglial activation in 14-MO females relative to youn-
ger, same-sex counterparts.
Identical analyses were performed at 7-DPI (Fig. 2).
Regarding proportional analyses, we observed a signifi-
cant main effect of age for MDMs compared to all mye-
loid (CD45+/CD11b+) cells (F(1, 7)=6.85, p<0.05; Fig. 2b)
and post hoc analyses revealed a significant increase in
4-MO males compared to 14-MO counterparts (p<0.05).
The proportion of microglia to myeloid cells was not
significantly affected by age (F(1, 7)=0.17, p=0.7) no sex
(F(1, 7)=1.5, p=0.3). Similarly, there were no significant
main effects in the proportion of neutrophils to total
myeloid cells with regard to age (F(1, 7)=0.16, p=0.7) or
sex (F(1, 7)=1.02, p=0.3). When comparing the proportion
of MDMs to microglia, we observed a trend for a main
effect of age (F(1, 7)=5.15, p=0.06) that was driven by in-
creases in the MDM/microglia ration in 4-MO males
compared to 14-MO males (p=0.1). There were no sig-
nificant main effects when examining cell counts (p=0.2)
for main effects of age or sex in the total number of
myeloid cells, MDMs, microglia, and neutrophils. Col-
lectively, our 7-DPI flow analyses indicate that the early,
3-DPI, age-, and sex-dependent inflammatory outcomes
largely normalized by 1-week post injury. While we did
observe some potential increases in MDMs in 4-MO
males at 7-DPI, it is important to note that a significant
mortality in 14-MO males after SCI precluded our abil-
ity to generate significant power in this group (n=2) and
we interpret any group differences between males with
caution. We have previously reported on this aged-male-
dependent mortality in a recent publication examining
the effect of sex on SCI outcomes [13].
Immunohistochemistry reveals a male-dependent
increase in microglia at 3-DPI
Flow cytometry analyses included the spinal cord tissue
encompassing multiple spinal levels (8 mm) [16] includ-
ing the entirety of lesion tissue. To better understand
the inflammatory response at the level of the lesion epi-
center, we generated tissue sections from 4- and 14-MO,
male and female mice, with and without SCI (Fig. 3 a,
b). To examine both cell types in situ, we sampled in-
jured tissue at the lesion epicenter (sections containing
the least amount of spared tissue) and generated cell
counts based upon P2y12 labeling of microglia and F4/
80 labeling of MDMs. In the absence of injury, P2y12+
microglia were evident with a ramified phenotype (Fig.
3a). As reported previously, there was little to no stain-
ing for F4/80, the pan marker for activated macrophages,
in uninjured tissue [17]. After SCI, F4/80+, round
macrophages were clearly discernable at the lesion epi-
center (Fig. 3). Microglia took on an amoeboid pheno-
type with P2y12 labeling punctate and concentrated in
and around the nucleus as reported previously [17].
Using criteria, we established previously for SCI [8], we
classified macrophages as MDMs (F4/80+ only) or
microglia (F4/80+/P2y12+ or P2y12+ only).
Similar to flow cytometry, there were no main effects
of sex or age in the density of total myeloid cells (F4/80+
macrophages) sampled (sex effect, F(1, 23)=0.0003, p=
0.99; age effect, F(1, 23)=1.04, p=0.3). Interestingly, for
MDM counts there were no main effects of sex (F(1, 23)=
0.21; p=0.6) or age (F(1, 23)=0.41; p=0.5) indicating that
MDM responses may be more widespread and that al-
tered microglia numbers at the lesion epicenter may be
driving the sex-dependent ratios observed using flow cy-
tometry. Indeed, for microglia, we observed a significant
main effect of sex (F(1, 23)=5.00; p<0.05) and a significant
sex by age interaction (F(1, 23)=4.23; p=0.05) with a trend
towards a main effect of age (F(1, 23)=3.68; p=0.07).
Microglia counts were significantly increased in 4-MO
males compared to 4-MO females (p<0.05) and 14-MO
males (p<0.05). This sex-dependent increase in microglia
is consistent with reports in TBI [9, 17] and may con-
tribute, at least in part, to the significantly high MDM/
microglia ratio found in females relative to males in our
flow analysis.
MDMs present with higher expression levels of activation-
and ROS-associated genes
Having identified that sex significantly alters the inflam-
matory response to SCI at the level of cellular recruit-
ment, we next examined the expression of phenotypic
genes in MDMs and microglia as a function of both sex
and age. MDMs and microglia were obtained from the
injured spinal cords at 3-DPI and sorted into collection
tubes using FACS based on gating strategies described
above (Fig. 1a). A custom NanoString code-set was pur-
chased to evaluate genes that were previously found to
be specifically upregulated when activated using classical
M1 (lipopolysaccharide and INFγ) and M2 (IL4) stimula-
tion paradigms in vitro [12]. Due to obtaining low num-
bers of cells during sorting, the NanoString paradigm
was not sensitive enough to reliably detect several genes
in our code set (n=10); these genes were mainly interleu-
kins and their receptors. All other genes that were reli-
ably detected above the threshold were assessed (n=27;
Table 1).
First, RNA obtained from MDMs and microglia were
compared to validate the sorting specificity. Samples
from all sex and age groups were combined and a small
subset of genes was separately analyzed as assay controls
using T tests to determine the sensitivity of discriminat-
ing MDMs from microglia, as well as to validate our
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FACS sorting purity (Fig. 4a). CX3CR1 (p<0.001),
P2y12 (p<0.001), and TMEM119 (p<0.001) were
assessed as microglia-specific genes and were specific-
ally expressed in our microglial populations. CCR2
(p<0.001) and H2-AB1 (p<0.001) were assessed as
MDM-specific genes and were specifically expressed
in our MDM populations. Results from these assay
controls validate the FACS sorting success and dem-
onstrates the sensitivity of discriminating between cell
types using NanoString (Fig. 4a).
Since both MDM and microglia responses differed
between males and females based upon our flow cy-
tometry and histological results, we next examined
the activation patterns between cell types. Samples
from all sex and age groups were combined and
used to compare the main effects between MDMs
and microglia using MANOVA (Fig. 4c). Comparing
main effects of cell type revealed a significant differ-
ence between MDMs and microglia in an overall ex-
pression of genes analyzed (F(1, 27)=388.02, p<0.05;
Fig. 4c). Of the 27 genes assessed, after controlling
for false discovery rate (FDR), all genes except
SOCS3 (q=0.055) were deemed significant discover-
ies. Of the 26 genes that were significantly differen-
tially expressed between MDMs and microglia, all
but 3 genes were upregulated in MDMs (Fig. 4b).
C1qa (p<0.001, q<0.001), CD86 (p<0.001, q<0.001),
and cPLA2 (p<0.001, q<0.001) were significantly in-
creased in microglia (Fig. 4b). This data suggests
that within and surrounding the injured spinal cord
Fig. 3 Younger male mice have a higher density of microglia within the lesion at 3-DPI. a, b Fixed tissue was obtained from male and female, 4-
and 14-MO mice at 3-DPI and immunolabeled for detection of MDMs (F4/80+ and P2y12-) and microglia (F4/80+ and P2y12+). b Microglia cell
counts presented with very heterogeneous morphology (arrows), ranging from ramified to ameboid. Monocytes are labeled consistently as large
cells with a brown membrane-associated labeling. Cell counts were normalized to the total area measured. c Total macrophages or MDM density
did not differ between groups, nor did the MDM/microglia ratios. c Cell count density of microglia was significantly increased in 4-MO males
compared to 4-MO females (p<0.05) and 14-MO males (p<0.05). Sample size include: 4-MO female (n=6), 4-MO male (n=7), 14-MO female (n=7),
and 14-MO male (n=7). Main effects were assessed using two-way ANOVA, followed by pairwise comparisons using Sidak’s for post hoc analysis
when appropriate. All graphs present SEM. Error bars represent 500 μm (a) and 100 μm (b). *p<0.05
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at 3-DPI, MDMs are the primary expressors of ROS
and conventionally defined M1 and M2 genes, while
microglia are the major expressors of genes associ-
ated with a debris response. Since we observed sex-
dependent MDM and microglia responses, these re-
sults implicate different secondary injury cascades in
males and females after SCI.
Being female after SCI increases activation- and ROS-
associated genes while being male increases complement
Next, we examined whether the phenotype of MDMs
and microglia differed by sex and age after SCI by exam-
ining differences in gene expression within each cell
type. Individual two-way MANOVA’s were performed
for each cell type to assess the main effects of sex and
Table 1 Gene expression differences. RNA obtained from FACS sorted MDMs and microglia were compared between cell type, sex,
and age. Estimated marginal means (EMM) were obtained following MANOVA to control for the combined variable when testing
sex and age, and the EMMs were used for comparisons using T test (p) with, and without, false discovery rate (FDR) correction (q)
using the two-stage step-up method of Benjamini, Krieger, and Yekutieli. Genes with fewer than 75% of samples testing below
detectable threshold were not compared. Genes are organized based on affiliated function as previously described [12]. Significant p
and q values were set to 0.05
Gene Common names Cell type MDMs Microglia
Sex Age Sex Age
p q p q p q p q p q
M1
activation
CD80 Cluster of differentiation 80 0.005* 0.001* 0.004* 0.057 0.788 1.000 0.049* 0.225 0.678 0.996
CD86 Cluster of differentiation 86 0.001* 0.001* 0.526 0.897 0.059 0.981 0.534 0.726 0.904 1.000
FCGR1 FC gamma receptor 1 (CD64) 0.005* 0.001* 0.087 0.396 0.855 1.000 0.936 0.940 0.830 0.996




IL4Ra Interleukin 4 receptor a 0.001* 0.001* 0.919 0.962 0.584 1.000 0.604 0.735 0.396 0.996
TNF Tumor necrosis factor 0.361 0.044* 0.370 0.894 0.562 1.000 0.866 0.909 0.252 0.996
STAT1 Signal transducer and activator of
transcription 1
0.253 0.032* 0.340 0.894 0.430 0.981 0.683 0.760 0.527 0.996
SOCS3 Suppressor of cytokine signalling 3 0.472 0.055 0.812 0.962 0.983 1.000 0.987 0.950 0.423 0.996
M2
activation
STAT3 Signal transducer and activator of
transcription 3
0.001* 0.001* 0.873 0.962 0.334 0.981 0.600 0.735 0.559 0.996
ARG1 Arginase-1 0.001* 0.001* 0.876 0.962 0.369 0.981 0.025* 0.195 0.955 1.000
CHI3L3 Chitinase 3-like-3 0.001* 0.001* 0.952 0.962 0.789 1.000 0.484 0.726 0.755 0.996
MANF Mes. astrocyte-derived neurotrophic factor 0.001* 0.001* 0.322 0.894 0.678 1.000 0.408 0.673 0.741 0.996
MRC1 Mannose receptor C-type 1 0.001* 0.001* 0.698 0.908 0.267 0.981 0.003* 0.036* 0.637 0.996




STAT6 Signal transducer and activator of
transcription 6
0.001* 0.001* 0.041* 0.277 0.391 0.981 0.375 0.666 0.023* 0.308
TGFβ1 Transforming growth factor β-1 0.001* 0.001* 0.052 0.283 0.323 0.981 0.069 0.264 0.362 0.996
ROS SOD2 Superoxide dismutase 2 0.02* 0.003* 0.523 0.897 0.959 1.000 0.144 0.333 0.466 0.996
CYBB Cytochrome b-245 (NOX2) 0.001* 0.001* 0.696 0.908 0.450 0.981 0.003* 0.036* 0.024* 0.308




HIF1a Hypoxia-inducible factor 1-α 0.001* 0.001* 0.015* 0.138 0.135 0.981 0.131 0.333 0.582 0.996
HMOX1 Heme oxygenase-1 0.001* 0.001* 0.230 0.785 0.351 0.981 0.210 0.441 0.434 0.996
IKBKB Inhibitor of NFKB 0.001* 0.001* 0.904 0.962 0.450 0.981 0.100 0.329 0.780 0.996
NFE212 Nuclear factor erythroid 2-related factor 2
(NRF2)
0.018* 0.003* 0.570 0.908 0.989 1.000 0.513 0.726 0.799 0.996
SOD1 Superoxide dismutase 1 0.001* 0.001* 0.446 0.894 0.836 1.000 0.047* 0.225 0.513 0.996
UCP2 Uncoupling protein 2 0.002* 0.001* 0.433 0.894 0.669 1.000 0.138 0.333 0.791 0.996
Debris C1qa Complement 1 subunit a 0.001* 0.001* 0.001* 0.018* 0.978 1.000 0.342 0.659 0.941 1.000
cPLA2 Phospholipase A2 0.001* 0.001* 0.685 0.908 0.187 0.981 0.691 0.760 0.724 0.996
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age, and the adjusted estimated marginal means (EMM)
were used for pairwise comparisons. A FDR adjustment
was performed on the EMMs obtained from each gene
that were corrected for either sex or age. Analysis of
MDMs revealed a significant main effect of sex (F(1, 11)=
288.21, p<0.05; Fig. 5a), and significant sex-dependent
differences in 4 of 27 genes analyzed with only 1 perse-
vering through the FDR adjustment. CD80 (p<0.01),
STAT6 (p<0.05), and HIF1α (p<0.05) were significantly
upregulated in females, while C1qa was significantly up-
regulated in males both pre- and post-FDR correction
(p<0.001, q<0.01; Fig. 5a). No genes were significantly in-
creased between ages in MDMs (F(1, 11)=4.79, p<0.34).
While there was no main effect of either sex (F(1, 10)=77.75,
p<0.08; Fig. 5b) or age (F(1, 10)=0.25, p<0.925; Fig. 5c) for
microglia, there were 5 of 24 analyzed genes significantly
Fig. 4 Activation-, ROS-, and debris-associated gene expression differs between MDMs and microglia at 3-DPI. MDMs and microglia were FACS
sorted into separate tubes at 3-DPI, and RNA was isolated. RNA expression was quantified in up to 27 genes associated with activation, ROS, and
debris response. a Genes known to be regulated specifically in MDMs or microglia were assessed to determine the purity and efficiency of FACS
sorting and were analyzed using T test. All other analyses of RNA counts were assessed using a one-way MANOVA to determine the main effects
between MDMs and microglia. Mean values were analyzed first by T test then by the two-stage step-up method of Benjamini, Krieger, and
Yekutieli for FDR adjustment to control for multiple comparisons. c All but 3 genes were differentially regulated between cell types (p<0.05, C);
SOCS3 (p=0.47), STAT1 (p=0.25), and TNF (p=0.36) were not different between MDMs and microglia. b All genes that were differentially regulated
between cells were upregulated in MDMs with three exceptions; C1qa (p<0.001, q<0.001), CD86 (p<0.001, q<0.001), and cPLA2 (p<0.001, q<0.001)
were upregulated in microglia. Sample size include MDMs (n=15) and microglia (n=14). All graphs present SEM. *Significant T test at least at p<
0.05, qsignificant discovery after FDR at least at q<0.05
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upregulated in females, with 2 persevering through the FDR
adjustment. Arg1 (p<0.05), CD80 (p<0.05), and SOD1 (p<
0.05) were significantly upregulated in females, with both
CYBB (p<0.01, q<0.05), and MRC1 (p<0.01, q<0.05) being
significantly upregulated in females both pre- and post-FDR
adjustment. CYBB (p<0.05) was also significantly upregulated
in 14-MO microglia, while STAT6 (p<0.05) was significantly
downregulated. Only 24 genes were analyzed in microglia
due to a loss of three genes being below the threshold for de-
tection; specifically, EPAS1, IL1β, and PPARγ were dropped
from the analysis. Pairwise comparisons following MANO-
VAs of both MDMs and microglia did not reveal any signifi-
cant interactions between sex and age for any genes.
Collectively, gene expression analyses indicate greater activa-
tion states in MDMs than microglia. Together, these analyses
identify complement as potentially being disproportionally
Fig. 5 Activation, ROS, and debris-associated gene expression differs by sex in a cell-dependent manner at 3-DPI. MDMs and microglia were FACS
sorted into separate tubes at 3-DPI, and RNA was isolated. RNA expression was quantified in up to 27 genes associated with activation, ROS, and
debris response. RNA counts were assessed using a two-way MANOVA to determine the main effects between sex and age within each cell type.
Because no interactions were found, the estimated marginal means with corresponding SEM’s were used to perform T tests and FDR analyses to
correct for the combined variable. a A main effect of sex was found in MDMs (p<0.05), with 4 genes being significant at the level of T test, and
only 1 gene persevering after FDR correction. a Specifically, CD80 (p<0.01, q=0.056), STAT6 (p<0.05, q=0.27), and HIF1α (p<0.05, q=0.13) were
significantly increased in female MDMs, with C1qa (p<0.001, q<0.01) being upregulated in male MDMs as a significant discovery. No significant
effects were found for age in MDMs. b Of 5 genes upregulated in female microglia, 2 were found to be significant discoveries. b Specifically,
CD80 (p<0.05, q=0.22), Arg1 (p<0.05, q=0.19), and SOD1(p<0.05, q=0.22) were significantly increased in female microglia, with CYBB (p<0.01, q<
0.05), and MRC1 (p<0.01, q<0.05), being significant discoveries after FDR correction. c Only two genes were significantly affected by age: STAT6
being decreased with age (p<0.05, q=0.30) and CYBB being increased with age (p<0.05, q=0.30). Sample size include females (MDMs, n=7;
microglia, n=6), males (MDMs, n=8; microglia, n=8), 4-MO (MDMs, n=6; microglia, n=6), 14-MO (MDMs, n=9; microglia, n=8). All graphs present
SEM. *Significant T test at least at p<0.05, qsignificant discovery after FDR at least at q<0.05
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activated in males due to a higher gene expression in MDMs
as well as the presence of more complement carrying micro-
glia. In contrast, females have a larger proportion of ROS-
producing MDMs with their microglia expressing more
ROS-associated genes.
Discussion
Data collected from our experiments support that in-
flammation after SCI is sex-dependent both at the level
of cellular recruitment and phenotype. Effects of aging,
while present, were less pronounced in microglial gene
expression. We found that MDM/microglia ratios
throughout the injured spinal cord of female mice were
larger, which may be partially explained by 4-MO male
mice having more microglia at the lesion epicenter. Fur-
ther, transcriptional profiles of MDMs and microglia in-
dicate that female macrophages are more robustly
activated after SCI and being both female and older in-
crease ROS-producing genes in microglia. In contrast,
male mice exhibit a unique increase in C1qa expression
in MDMs with a concurrent increase in microglial dens-
ity at the lesion epicenter. Collectively, these data indi-
cate that inflammatory profiles are sex-dependent after
SCI and that mechanisms of secondary injury may di-
verge towards females having more ROS-, and males
having more complement-driven pathology.
There is increasing evidence that the pathophysiology and
recovery after SCI may be sex-dependent [13, 14, 18–23].
This is especially true for neuropathic pain where sex-
dependent outcomes have been observed in both humans
and rodents [24–26]. Further, we have recently observed that
the effectiveness of immunomodulatory analgesics is sex-
dependent [27]. Pain development post-SCI is associated
with inflammation and inflammatory cascades within the
SCI lesion and lumbar spinal cord [28–30]. Here, we demon-
strate that inflammatory recruitment in response to SCI is
indeed sex-dependent, which provides a foundation to begin
understanding sex differences in neuropathology and post-
SCI complications, such as pain, that arise after injury.
In addition to sex differences in cellular recruitment,
we observed important differences in gene profiles of
two important pathways involved in secondary injury
cascades. Specifically, females had an increase in activa-
tion, as well as ROS-associated genes, while males had
an increase in C1qa of the complement pathway. Previ-
ously, we have reported in data from only female mice,
that age increases NOX2 and ROS damage, which
worsens function after SCI [8]. NOX2 may play a larger
role in SCI pathophysiology in female mice as, in the
current study, we detected that NOX2 was increased in
female microglia compared to males, which was further
increased with age. Our observation of increased CYBB
expression (gene encoding for NOX2) with age is con-
sistent with prior studies conducted in females [7, 31].
Male-dependent increases in C1qa in MDMs after SCI
has not been reported previously. Not only was C1qa
significantly increased in male MDMs, but males also
possessed more microglia within the SCI lesion, of which
microglia are the primary native producers of comple-
ment in the nervous system. Indeed, we detected a
roughly five-fold increase in C1qa gene expression in
microglia compared to MDMs. These data collectively
point to potentially meaningful differences driving sex-
dependent pathology after SCI.
It remains important to consider that even if differ-
ences in functional outcomes are subtle between sexes
or age after SCI [14], that the molecular and biological
responses can be considerably different [13]; our data
supports this concept. Implications for such discrepan-
cies in biological responses are that treatments tailored
to any given mechanism may also exert sex-dependent
or age-dependent effects [32]. For example, previous
work from our lab has used pioglitazone to treat SCI
pain and found a significant analgesic effect in female,
but not male, mice [27]. While the mechanisms under-
lying this sex-dependent analgesic effect are unknown,
there have been reports of estrogen directly influencing
pioglitazone biological target, PPARγ [33–35], as well as
reports of the increased potency of pioglitazone on insu-
lin sensitization in females [36]. Here, we have found
that NOX2 and C1qa may play larger contributors to
SCI pathology in female and male mice, respectively.
Further, we observed that MDM/microglia ratios are sig-
nificantly affected by age. Considering our prior work
demonstrating age-dependent and age-divergent thera-
peutic efficacy of NOX2 inhibition and other therapies
targeting ROS in female mice [8, 37], future work should
determine if a similar effect is shared in males.
As part of the complement cascade, C1qa plays an im-
portant role in responding to cellular debris after injury
and apoptosis [38–40]. However, C1qa after SCI is also a
known contributor to secondary injury cascades [39, 41,
42]. When C1qa is globally knocked out or suppressed,
mice perform better on locomotor tasks and lesion se-
verity is reduced [41]. While the role of C1qa as a sex-
dependent exacerbator of SCI has not yet been exam-
ined, both age and sex are known to differentially affect
complement activation in the blood of healthy adult
humans [43] and mice [41]. Our findings have specific-
ally identified a male-dependent increase in C1qa within
infiltrating monocytes after SCI, with a further male-
dependent increase in microglial counts, which are the
largest producers of C1qa within the spinal cord. Owing
to the strong contribution of complement to SCI path-
ology, future work should evaluate potential sex differ-
ences in targeting complement activation as a therapy.
Male- and female-associated sex hormones differen-
tially affect inflammation in response to injury or
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infection; therefore, similar sex-dependent inflammatory re-
sponses to neurotrauma are likely [44–48]. Indeed, differ-
ences in acute inflammatory profiles between sexes exist
following brain injury, specifically finding an increase in
microglia and total inflammation in male rodents at 3-DPI
[9, 17]. This finding is consistent with suggestions that tes-
tosterone may enhance microglial activation but is inconsist-
ent with reports that testosterone suppresses MDMs [48,
49]. In contrast, estrogens have been found to increase
MDM activation and suppress microglia [44, 45, 47].
Increased age at the time of SCI also affects inflamma-
tion by both increasing leukocyte infiltration as well as
changing genetic expression of activation- and ROS-
associated genes [6, 7, 31]. Our lab has found that ad-
vanced age at the time of SCI increases total inflamma-
tion by 3-DPI and shifts macrophage phenotypes
towards a more aggressive ROS-producing profile [7, 8].
This increase in ROS damage with age corresponds with
an increase in macrophage-specific NOX2 expression,
which can be mitigated in an age-dependent manner
using apocynin as a NOX2 inhibitor [8]. Apocynin re-
duced ROS production in a cell-specific manner, specif-
ically reducing MDM-derived ROS [8]. Data presented
in this study further corroborates the role of age on in-
creasing NOX2 expression and identified microglia as
the macrophage cell-type that is most affected by aging.
It is important to consider technical differences in flow
cytometry and immunohistochemistry methods of ana-
lysis that can partially explain discrepancies between
these data. First, when extracting spinal cords for flow
cytometry, a consistent length of cord was removed.
Overall cell numbers did not differ among groups mak-
ing it unlikely that an increased spinal cord size reported
with advanced age influenced our results [50]. We deter-
mined cell counts through flow cytometry without
normalization to total tissue or lesion size. Indeed, our
observation of increased MDMs/microglia ratios in 4-
vs. 14-MO females is consistent with previous histo-
logical examination when total cell numbers were
counted without normalization to tissue area [8]. Since
we previously observed that the rostral-caudal length of
the lesion increases in males vs. females and in 14- vs. 4-
MO mice [6, 14], we only examined the lesion epicenter
and normalized to tissue area for histological cell counts.
It is not surprising, therefore, that we did not make the
same observations with histological and flow analyses.
Indeed, our histological analyses revealed a consistent
MDM density between groups; however, we detected a
significant increase in microglial density within the le-
sion of 4-MO males. Immune cells within the lesion core
are predominately MDMs, making our observation of in-
creased microglial responses in males intriguing, and
collectively, we conclude that the profile of inflammation
after SCI is sex-dependent.
Our findings of increased activation- and ROS-
associated genes in MDMs relative to microglia
should be interpreted with caution. When extracting
myeloid cells from the injured spinal cords a region
of tissue is isolated that is slightly larger than the im-
mediate lesioned environment. This will result in iso-
lating microglia at distances away from the lesion that
may have not yet been recruited or activated from in-
jury. In contrast, all infiltrating MDMs are likely acti-
vated through the migratory process, which would
result in a larger percentage of the MDM population
expressing activation genes. Our data comparing
mRNA from MDMs vs microglia may simply reflect
the fact that isolated mRNA is derived from a frac-
tion of activated microglia, whereas likely all MDM
mRNA came from activated cells. Or, alternatively,
the association between classically defined M1 and
M2 genes obtained from in vitro paradigms, as previ-
ously reported [12], may indeed be a better represen-
tation of gene expression profiles of activated MDMs
compared to microglia. Nevertheless, microglia did
persist to demonstrate an increased expression of the
two genes, C1qa and CPLA2, which may underly crit-
ical functional differences in cellular and sex-
dependent responses after SCI.
Conclusions
Collective data, presented here, confirm a sex-
dependent inflammatory effect at both the level of
cell infiltration as well as gene expression profile.
Consistent with reports in TBI [9], we have found an
increased density of microglia in male mice, with a
corresponding increase in the proportion of mono-
cytes in female mice, after SCI. Further, we have vali-
dated that the gene transcript encoding complement
protein C1qa is indeed increased in males [41], specif-
ically finding an increased expression in male MDMs.
In addition to male-dependent complement activation,
our findings indicate that the response of microglia
and monocyte-derived macrophages are both age and
sex-dependent after SCI with increased NOX2 expres-
sion in microglia from female and older animals.
Findings from this study highlight the importance of
considering both age and sex as important biological
variables in the pathophysiology and immunomodula-
tory treatment of spinal cord injury.
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